Search ARM

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products processed from human amniotic membrane.

“Innovations in Regenerative Biomaterials” is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarian births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary PURION® Process to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 100,000 implants to date to distributors and OEMs for applications in the Ophthalmic, Orthopedic, Spine, Wound Care, and Dental sectors of healthcare.

Our platform technologies, AmnioFix®, EpiFix®, HydroFix® and CollaFix™, have such a vast number of potential applications in treating traumatized tissue and structures that it is difficult to accurately quantify. MiMedx Group is focused on commercializing multiple applications of all four technologies. In parallel, we are seeking strategic relationships to more rapidly commercialize our technologies.

Contact MiMedx
(866) 477-4219
Visit Website